Concord Drugs informs about standalone financial results

14 Nov 2016 Evaluate

Concord Drugs has informed about Standalone Financial Results, Limited Review Report for the period ended September 30, 2016.

The above information is a part of company’s filings submitted to BSE.

Concord Drugs Share Price

38.00 0.39 (1.04%)
01-Nov-2024 18:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1858.70
Dr. Reddys Lab 1258.55
Cipla 1559.20
Lupin 2198.25
Zydus Lifesciences 1004.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.